Pricing Log in Create free account

Immunic, Inc. (IMUX) vs Unicycive Therapeutics, Inc. (UNCY)

Immunic, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. Immunic, Inc. and Unicycive Therapeutics, Inc. are of similar size ($99.9M and $96.9M). Across the 8 metrics below, Unicycive Therapeutics, Inc. leads on 5 and Immunic, Inc. on 3.

Valuation

Metric IMUX UNCY Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.60 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (56.15%) (45.67%) (32.88%)
Free cash flow yield (26.55%) (29.31%) (23.13%)

Profitability

Metric IMUX UNCY Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.17%) (101.07%) (51.96%)
Return on assets (101.15%) (69.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMUX UNCY Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 38.00% 70.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 3.81 4.97
Net debt to EBITDA 0.15 1.43 1.01

Dividend

Metric IMUX UNCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMUX UNCY Biotechnology median
Market cap 99.88m 96.94m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack